<!DOCTYPE html>
<html lang="en">
<head>
<title>Frequency of Donation</title>
<meta http-equiv="Content-Type" content="text/html;charset=utf-8">
<link rel="stylesheet" type="text/css" href="../../../public/css/offline.css" />
<script src="../../../public/javascripts/jquery-1.10.2.min.js"></script>
</head>
<body class="dsg-wb">

<table width="80%" class="offline">
<tr>
  <td colspan="3" class="header"><h1><a href="/">JPAC</a> <span>Joint United Kingdom (UK) Blood Transfusion and Tissue Transplantation Services Professional Advisory Committee</span></h1></td>
</tr>
<tr class="tabs">
  <td colspan="3">
              <ul>
                  <li id="64df60ce-a8e2-4c07-8729-68f41eb42fc3" class="whole-blood-and-components"><a href="../../../dsg/wb/guidelines.html"  class="active">Whole Blood and Components</a></li>
                  <li id="ddb09bf2-3dc0-4eb2-ba57-a5db69331dd1" class="geographical-disease-risk-index"><a href="../../../dsg/gdri/guidelines.html" >Geographical Disease Risk Index</a></li>
                </ul>
        </td>
</tr>
<tr>
  <td class="spacerow" colspan="3"></td>
</tr>
<tr>
  <td class="sidebar" width="25%">
    <div class="well">
          <ul class="openContentSectionWithSubs sidebarTopHeader"><li id="64df60ce-a8e2-4c07-8729-68f41eb42fc3" class="whole-blood-and-components sectionHead first last"><a href="../../../dsg/wb.html">Whole Blood and Components</a>
<ul class="">
<li id="42be2de8-89aa-4908-8bc8-702f9e636a81" class="a-z-search active first"><a href="../../../dsg/wb/guidelines.html">A-Z Search</a>
</li><li id="1f7e1f13-8b29-4772-ae9d-2b5cc3d59491" class="updates"><a href="../../../dsg/wb/latest-updates.html">Updates</a>
</li><li id="f83d68fb-19de-4588-9a36-a8bba0aa6494" class="drug-index"><a href="../../../dsg/wb/drug-index.html">Drug Index</a>

</li><li id="769da873-1c35-4600-8be8-d2df902570a0" class="preliminaries"><a href="../../../dsg/wb/preliminaries.html">Preliminaries</a>
<ul class="">
<li id="258895c3-f3dd-45c6-932c-3fe4795870c2" class="introduction first"><a href="../../../dsg/wb/preliminaries/introduction.html">Introduction</a>
</li><li id="ef298454-8327-4f6c-9f4a-835e437df103" class="document-and-change-control"><a href="../../../dsg/wb/preliminaries/document-and-change-control.html">Document and Change Control</a>
</li><li id="093e6463-a089-49dd-9199-c8f92559f486" class="general-principles"><a href="../../../dsg/wb/preliminaries/general-principles.html">General Principles</a>
</li><li id="96f75c3a-2c62-445b-847c-353098eaec1e" class="medication"><a href="../../../dsg/wb/preliminaries/medication.html">Medication</a>
</li><li id="ed51942d-a7fd-42f7-8269-d23b879f99ca" class="inspection-of-the-donor"><a href="../../../dsg/wb/preliminaries/inspection-of-the-donor.html">Inspection of the Donor</a>
</li><li id="99af8b5e-491b-4d67-b69a-812d81af4d7d" class="use-of-alphabetical-listing last"><a href="../../../dsg/wb/preliminaries/use-of-alphabetical-listing.html">Use of Alphabetical Listing</a>
</li></ul>
</li><li id="753eb36f-2636-414c-84ee-1004e197502d" class="appendices"><a href="../../../dsg/wb/appendicies.html">Appendices</a>
<ul class="">
<li id="e147bd96-a025-4ffa-b530-b9abefc27043" class="appendix-1---estimated-blood-volume-for-female-donors-after-nadler--by-height-and-weight first"><a href="../../../dsg/wb/appendicies/appendix-1.html">Appendix 1 - Estimated Blood Volume for Female donors (after Nadler)  by height and weight</a>
</li><li id="2f1eca54-e34f-4ece-90a4-7dfe0f210c8d" class="appendix-2---table-of-immunisations-"><a href="../../../dsg/wb/appendicies/appendix-2-table-of-immunizations.html">Appendix 2 - Table of Immunisations </a>
</li><li id="a27f8ce9-b4f6-4a9b-baf0-6f655955a9aa" class="appendix-3---maximum-permitted-ecv-for-component-donors"><a href="../../../dsg/wb/appendicies/appendix-3-maximum-permitted-extra-corporeal-volume-for-component-donors.html">Appendix 3 - Maximum permitted ECV for component donors</a>
</li><li id="90c869cb-7256-4604-8699-d8a86f78aa26" class="appendix-4---management-of-post-donation-illness last"><a href="../../../dsg/wb/appendicies/appendix-4-management-of-post-donation-illness.html">Appendix 4 - Management of post donation illness</a>
</li></ul>
</li><li id="b62a2d12-6d94-4106-92a8-1de426a4b863" class="source-files last"><a href="../../../dsg/wb/source-files.html">Source Files</a>
</li></ul>
</li></ul>
    </div>
  </td>
  <td width="5%"></td>
  <td width="70%" class="content">
    <h2>Frequency of Donation</h2>    

<table class="data-table"><tbody><tr class="data-row"><td class="data-label">Discretionary</td><td class="data-value"><p><b>1. Whole Blood:</b></p>


<p><br />
A minimum interval of 12 weeks between donations should normally be observed.</p>


<p><br />
Donors who regularly attend at intervals of less than 16 weeks should be informed that they are at increased risk of iron deficiency. They should be advised to reduce their frequency of donation to an average of 16 weeks or more.</p>


<p><br />
Donors with genetic haemochromatosis may donate at intervals of less than 12 weeks.</p>


<p>&nbsp;</p>


<p><b>2. Components:</b></p>


<p><br />
<b>a) Double Red Cells:</b></p>


<p><br />
A minimum interval of 26 weeks between donations should normally be observed.</p>


<p><br />
Donors who attend at intervals of less than 32 weeks should be informed that they are at increased risk of iron deficiency. They should be advised to reduce their frequency of donation to an average of 32 weeks or more.</p>


<p><br />
Donors with genetic haemochromatosis may donate at intervals of less than 26 weeks.</p>


<p>&nbsp;</p>


<p><b>b) Apheresis Platelets and/or Plasma:</b></p>


<p><br />
A minimum interval of two weeks between donations should normally be observed. The combined total of platelet and plasma donations in any 12-month period should not be more than 26.</p>


<p><br />
Donors of convalescent plasma can donate at weekly intervals, provided they meet all other requirements for plasma donation. They should not donate more than 26 donations in any 12-month period.</p>


<p><br />
Donors who attend at intervals of less than four weeks may be at increased risk of iron deficiency.</p>


<p>&nbsp;</p>


<p><b>c) Stem Cell Donors:</b></p>


<p><br />
A donor should not give any routine donations for six months following bone marrow harvest and for three months following peripheral blood stem cell harvest or lymphocyte donation.</p>


<p>&nbsp;</p>


<p><b>d) Donors who change donation type:</b></p>


<p><br />
Care must be taken to ensure that limits on the frequency of donation are maintained for donors who move between donation types.</p>


<p><br />
The following deferral periods should be applied:</p>


<p><br />
Donors moving from whole blood to component donation (except double red cells):</p>


<p><br />
4 weeks</p>


<p><br />
Donors moving from platelet or plasma component donation to whole blood:</p>


<p><br />
4 weeks since last component donation (and at least 12 weeks since the most recent whole blood donation)</p>


<p><br />
Donors moving from whole blood to double red cell donation:</p>


<p><br />
12 weeks.</p>


<p><br />
Donors moving from double red cell donation to other component donation:</p>


<p><br />
8 weeks.</p></td></tr><tr class="data-row"><td class="data-label">Additional Information</td><td class="data-value"><p>The various intervals are to minimise the risk of developing iron deficiency, except for the deferral periods following stem cell or lymphocyte donation &laquo;which are in place to allow the donor to be available for further stem cell or lymphocyte donations should this be required.<br />
<br />
Stem cells and lymphocytes are collected by apheresis.</p></td></tr><tr class="data-row"><td class="data-label">Reason for change</td><td class="data-value"><p>The deferral periods after bone marrow or stem cell donation have been reduced in keeping with WMDA guidelines.</p></td></tr><tr class="data-row"><td class="data-label">Donor Information</td><td class="data-value"><p>If you wish to obtain more information regarding a personal medical issue please contact your <a href="../../../dsg/wb/guidelines/nn099-national-help-lines.html">National Help Line</a>.<br />
<br />
Please do not contact this web site for personal medical queries, as we are not in a position to provide individual answers.</p></td></tr></tbody></table>
<div class="pull-right attachments"><div class="cms images">
  
</div></div>

  
<dl class="update-information"><dt class="data-label"><h4>Update Information</h4></dt><dd class="data-value"><p>This entry was last updated in:<br />
DSG-WB Edition 203, Release 68</p></dd></dl>  </td>
</tr>
</table>
</body>
</html>